Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

Compare more Genetics professors.

h-index115
i10-index243
Publications528
Citations87,966

Grants

8 total · 2 active

NIH #R01NS144449

Targeting MBD2 for medulloblastoma therapy

Active
Amount
$500K–$600K
Period
2025-09-09 → 2030-08-31
PIs
1

NIH #P30CA013148

Shared Resource Management

Active
Amount
$2M–$3M
Period
1997-03-28 → 2027-03-31
PIs
1

NIH #R01NS117666

Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.

Amount
$400K–$500K
Period
2021-09-15 → 2026-07-31
PIs
1

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 2 active

NIH #R01NS144449

Targeting MBD2 for medulloblastoma therapy

Active
Amount
$500K–$600K
Period
2025-09-09 → 2030-08-31
PIs
1

NIH #P30CA013148

Shared Resource Management

Active
Amount
$2M–$3M
Period
1997-03-28 → 2027-03-31
PIs
1

NIH #R01NS117666

Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.

Amount
$400K–$500K
Period
2021-09-15 → 2026-07-31
PIs
1

NIH #R01CA235162

Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma

Amount
$400K–$500K
Period
2019-09-01 → 2025-01-31
PIs
1

NIH #R01NS096236

Targeting mechanisms of medulloblastoma formation

Amount
$300K–$400K
Period
2016-07-01 → 2020-02-01
PIs
1

Awarded at EMORY UNIVERSITY

NIH #R01CA176001

Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis

Amount
$300K–$400K
Period
2013-12-15 → 2018-11-30
PIs
2

Awarded at EMORY UNIVERSITY

NIH #R01CA163722

Defining mechanisms of extracellular communication for cancer therapy

Amount
$300K–$400K
Period
2013-04-01 → 2018-03-31
PIs
1

Awarded at EMORY UNIVERSITY

NIH #P30CA138292

Cancer Cell Biology

Amount
$500K–$600K
Period
— → —
PIs
1

Awarded at EMORY UNIVERSITY

Recent Public Signals

  1. New paper: Therapeutic targeting of adhesion GPCRs: a status update and future potential (Expert Opinion on Drug Discovery)2026-04-24
  2. New NIH award: Targeting MBD2 for medulloblastoma therapy2025-09-09
  3. New preprint: Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas2025-07-15

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-01

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-2444-7707

Professor Insights

Career Trajectory